Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Cara Therapeutics, Inc. (CARA)  
$0.77 0.01 (1.79%) as of 4:30 Thu 5/2


Download
   
Exchange: N/A
Security Type: N/A
Shares Out: 49,830,000
Market Cap: 38.48(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.5201 - $4.45
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Cara Therapeutics is an early commercial-stage biopharmaceutical company focusing on a new treatment paradigm to improve the lives of patients suffering from pruritus. Co.'s KORSUVA injection is an FDA-approved treatment for moderate-to-severe pruritus associated with chronic kidney disease, in adults undergoing hemodialysis. Co. is developing an Oral KORSUVA (difelikefalin) formulation for the treatment of pruritus in patients with atopic dermatitis, and non-dialysis-dependent chronic kidney disease. Phase 2 trials of Oral KORSUVA (difelikefalin) are ongoing in primary biliary cholangitis, and in notalgia paresthetica patients with moderate-to-severe pruritus.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 58,482 58,482 74,857 179,408
Total Sell Value $37,219 $37,219 $96,243 $919,932
Total People Sold 3 3 4 8
Total Sell Transactions 7 7 12 31
End Date 2024-02-01 2023-10-31 2023-05-02 2022-05-02

   
Records found: 307
  Page 3 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Terrillion Scott Secy; Chief Compliance & G.C.   •       –      –    2022-04-01 4 AS $11.91 $19,556 D/D (1,642) 102,344 -8%     
   Menzaghi Frederique Ph.d. Chief Scientific Off,SVP-R&D   •       –      –    2022-04-01 4 AS $11.91 $21,247 D/D (1,784) 169,781 -8%     
   Terrillion Scott Secy; Chief Compliance & G.C.   •       –      –    2022-03-03 4 AS $11.38 $20,336 D/D (1,787) 103,986 -13%     
   Reilly Thomas Charles Chief Financial Officer   •       –      –    2022-03-03 4 AS $11.38 $23,261 D/D (2,044) 37,811 -13%     
   Terrillion Scott Secy; Chief Compliance & G.C.   •       –      –    2022-02-28 4 A $0.00 $0 D/D 5,333 105,773     -
   Reilly Thomas Charles Chief Financial Officer   •       –      –    2022-02-28 4 A $10.29 $54,877 D/D 5,333 39,855     -
   Goncalves Joana Chief Medical Officer   •       –      –    2022-02-25 4 AS $10.29 $20,292 D/D (1,972) 76,535 -9%     
   Goncalves Joana Chief Medical Officer   •       –      –    2022-02-25 4 A $0.00 $0 D/D 20,000 78,507     -
   Posner Christopher President and CEO   •       •      –    2022-02-25 4 A $0.00 $0 D/D 39,000 203,037     -
   Menzaghi Frederique Ph.d. Chief Scientific Off,SVP-R&D   •       –      –    2022-02-25 4 AS $10.29 $21,753 D/D (2,114) 171,565 -9%     
   Menzaghi Frederique Ph.d. Chief Scientific Off,SVP-R&D   •       –      –    2022-02-25 4 A $0.00 $0 D/D 20,000 173,679     -
   Terrillion Scott Secy; Chief Compliance & G.C.   •       –      –    2022-02-25 4 AS $10.29 $20,292 D/D (1,972) 100,440 -9%     
   Terrillion Scott Secy; Chief Compliance & G.C.   •       –      –    2022-02-25 4 A $0.00 $0 D/D 20,000 102,412     -
   Reilly Thomas Charles Chief Financial Officer   •       –      –    2022-02-25 4 A $0.00 $0 D/D 20,000 34,522     -
   Reilly Thomas Charles Chief Financial Officer   •       –      –    2021-12-17 4 A $0.00 $0 D/D 11,170 14,522     -
   Goncalves Joana Chief Medical Officer   •       –      –    2021-12-17 4 A $0.00 $0 D/D 12,607 58,507     -
   Terrillion Scott Secy; Chief Compliance & G.C.   •       –      –    2021-12-17 4 A $0.00 $0 D/D 11,495 82,412     -
   Menzaghi Frederique Ph.d. Chief Scientific Off,SVP-R&D   •       –      –    2021-12-17 4 A $0.00 $0 D/D 12,607 153,679     -
   Goncalves Joana Chief Medical Officer   •       –      –    2021-11-01 4 AS $17.15 $17,150 D/D (1,000) 45,900 -35%     
   Posner Christopher Senior Advisor   –       •      –    2021-10-29 4 A $0.00 $0 D/D 147,941 164,037     -
   Goncalves Joana Chief Medical Officer   •       –      –    2021-10-27 4 AS $15.00 $15,000 D/D (1,000) 46,900 -25%     
   Vifor Fresenius Medical Care Renal Pharma Ltd. 10% Owner   –       –       •   2021-10-20 3 IO $0.00 $0 I/I 0 7,396,770 -14%     
   Chalmers Derek T President & CEO   •       •      –    2021-09-07 4 S $15.47 $309,400 D/D (20,000) 991,405 26%     
   Menzaghi Frederique Ph.d. Chief Scientific Off,SVP-R&D   •       –      –    2021-08-30 4 AS $14.20 $54,627 D/D (3,847) 141,072 -18%     
   Chalmers Derek T President & CEO   •       •      –    2021-08-30 4 AS $14.20 $119,848 D/D (8,440) 1,011,405 -18%     
  307 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 3 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us